Basamshetty, V.V.; Gangipangi, V.K.; Kumar, U.S.; Shanthi Bhupathi, S.; Kaulagari, S.R.; Giri, P.; Sinha, S.; Mohan, U.; Sdrimas, K.
Novel In Vitro Selection of Trans-Acting BCL-2 mRNA-Cleaving Deoxyribozymes for Cancer Therapy. Cells 2025, 14, 945.
https://doi.org/10.3390/cells14130945
AMA Style
Basamshetty VV, Gangipangi VK, Kumar US, Shanthi Bhupathi S, Kaulagari SR, Giri P, Sinha S, Mohan U, Sdrimas K.
Novel In Vitro Selection of Trans-Acting BCL-2 mRNA-Cleaving Deoxyribozymes for Cancer Therapy. Cells. 2025; 14(13):945.
https://doi.org/10.3390/cells14130945
Chicago/Turabian Style
Basamshetty, Veera Vijaya, Vijay Kumar Gangipangi, Uppulapu Shravan Kumar, Santhosh Shanthi Bhupathi, Sridhar Reddy Kaulagari, Prashant Giri, Swapnil Sinha, Utpal Mohan, and Konstantinos Sdrimas.
2025. "Novel In Vitro Selection of Trans-Acting BCL-2 mRNA-Cleaving Deoxyribozymes for Cancer Therapy" Cells 14, no. 13: 945.
https://doi.org/10.3390/cells14130945
APA Style
Basamshetty, V. V., Gangipangi, V. K., Kumar, U. S., Shanthi Bhupathi, S., Kaulagari, S. R., Giri, P., Sinha, S., Mohan, U., & Sdrimas, K.
(2025). Novel In Vitro Selection of Trans-Acting BCL-2 mRNA-Cleaving Deoxyribozymes for Cancer Therapy. Cells, 14(13), 945.
https://doi.org/10.3390/cells14130945